Alnylam Pharmaceuticals, Inc.

ALNY·NasdaqGS·Healthcare
Compare
161.08+1.19 (+0.74%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market164.46+3.38 (+2.10%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close159.89
Open166.73
Day range160.29170.49
52-week range156.00479.79
Off day high−5.52%
Off 52-week high−66.43%
Volume3.47M
Avg. volume (3M)1.88M
Market cap21.57B
EPS (TTM)19.80
Forward P/E14.45
P/E ratio (TTM)8.14
Dividend yield—
Beta (5Y)0.44
Shares outstanding133.94M
Short interest6.54% of float
Earnings dateOct 29, 2026
Analyst target302.48
Profit margin52.85%

Against its peers

Compare in full ›
ALNY IONS ARWR BBIO ROIV 4591.T
Market cap 21.57B 6.67B 8.71B 15.17B 27.61B 3.39B
P/E (TTM) 8.1 — — — — —
Forward P/E 14.4 -35.0 -12.4 -225.0 -27.5 -1.1
Price/book 6.0 15.1 18.7 -5.9 6.5 1.2
Dividend yield — — — — — —
1-year change −63.43% −45.82% +55.68% +24.17% +85.85% −29.21%
Today +0.74% −0.67% +3.56% +5.21% +6.08% −4.76%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Alnylam Pharmaceuticals's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Ionis Pharmaceuticals, Inc.IONS · Biotechnology 6.67B 40.15 −0.67%
Arrowhead Pharmaceuticals, Inc.ARWR · Biotechnology 8.71B 61.65 +3.56%
BridgeBio Pharma, Inc.BBIO · Biotechnology 15.17B 77.89 +5.21%
Roivant Sciences Ltd.ROIV · Biotechnology 27.61B 38.23 +6.08%
Ribomic Inc.4591.T · Biotechnology 3.39B 60.00 −4.76%
Ascentage Pharma Group International6855.HK · Biotechnology 11.30B 30.240 +6.70%
ADARx Pharmaceuticals, Inc.ADRX · Biotechnology 1.66B 14.96 −7.02%
Sarepta Therapeutics, Inc.SRPT · Biotechnology 2.01B 18.99 +2.43%

Also based in Cambridge, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Moderna, Inc.MRNA · Cambridge, MAOdds 103.15B 258.38 +13.11%
Biogen Inc.BIIB · Cambridge, MA 37.61B 254.46 +2.22%
Akamai Technologies, Inc.AKAM · Cambridge, MAOdds 12.35B 85.93 −0.69%
GE Vernova Inc.GEV · Cambridge, MA 220.43B 832.83 −9.30%
HubSpot, Inc.HUBS · Cambridge, MA 11.09B 216.64 −4.21%
Nuvalent IncNUVL · Cambridge, MA 9.81B 123.96 0.00%
Scholar Rock Holding CorporationSRRK · Cambridge, MA 5.61B 46.09 +4.80%
Relay Therapeutics, Inc.RLAY · Cambridge, MA 3.95B 18.03 +3.38%

The stocks whose daily moves over the past year went most closely with Alnylam Pharmaceuticals's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Sarepta Therapeutics, Inc.SRPT · Correlation 0.33 2.01B 18.99 +2.43%
Ionis Pharmaceuticals, Inc.IONS · Correlation 0.32 6.67B 40.15 −0.67%

What visitors to Alnylam Pharmaceuticals's page also look at.

Company Mkt cap Price Today
BioMarin Pharmaceutical Inc.BMRN 11.06B 57.13 +2.64%
Ionis Pharmaceuticals, Inc.IONS 6.67B 40.15 −0.67%
Incyte CorporationINCY 25.04B 122.85 +4.47%
Sarepta Therapeutics, Inc.SRPT 2.01B 18.99 +2.43%
Neurocrine Biosciences, Inc.NBIX 16.81B 166.05 +0.73%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All ALNY news ›
Seeking Alpha·Negative

Alnylam downgraded at Truist on Amvuttra outlook

Truist cut Alnylam to hold on Amvuttra sales uncertainty, lowering forecasts and price target. Read more here. - Truist downgraded Alnylam Pharmaceuticals (ALNY) to hold from buy, citing a lack of clarity on the sales outlook for the…

ALNYALDX
Stock Titan·Positive

Alnylam automatically sells 1,758 shares for Supran

Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01 Lucid Diagnostics Begins Receiving Medicare Reimbursement for…

ALNYNVDA

From the 4Search news index, newest first.

In the news

28mentions in 30 days
18with it in the headline
Mixedsentiment

Mentioned with

Alnylam24Alnylam Pharmaceuticals, Inc20Alnylam Pharmaceuticals, Inc.19Pfizer11Astrazeneca10Eli Lilly and Company9Oppenheimer8Eli Lilly7

People in the coverage

Kirby Mcinerney17Kim Johansen16Marketbeat16Amvuttra14Danessa Lincoln14Michael Walen13

Themes

Healthcare21SEC Filings13Lly1102043Q1010Rnai913F8Biotechnology8EPS7

Most coverage from

  1. seekingalpha.com12
  2. themarketsdaily.com8
  3. defenseworld.net3
  4. 247wallst.com1
  5. fool.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 28 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance